APT Medical Inc. (688617.SS)
CNY 359.11
(-1.08%)
CNY 359.11
(-1.08%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.11 Billion CNY | 28.74% |
| 2022 | 865.85 Million CNY | 50.36% |
| 2021 | 575.84 Million CNY | 70.72% |
| 2020 | 337.3 Million CNY | 17.91% |
| 2019 | 286.07 Million CNY | 72.03% |
| 2018 | 166.28 Million CNY | 57.76% |
| 2017 | 105.4 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 380.23 Million CNY | -0.34% |
| 2024 Q1 | 322.06 Million CNY | 9.8% |
| 2024 Q2 | 381.54 Million CNY | 18.47% |
| 2023 Q4 | 293.31 Million CNY | -2.58% |
| 2023 Q2 | 318.12 Million CNY | 28.73% |
| 2023 FY | 1.11 Billion CNY | 28.74% |
| 2023 Q1 | 247.12 Million CNY | 4.74% |
| 2023 Q3 | 301.07 Million CNY | -5.36% |
| 2022 Q2 | 205.78 Million CNY | 11.08% |
| 2022 Q4 | 235.94 Million CNY | -1.22% |
| 2022 Q3 | 238.86 Million CNY | 16.07% |
| 2022 FY | 865.85 Million CNY | 50.36% |
| 2022 Q1 | 185.25 Million CNY | 14.89% |
| 2021 Q4 | 161.25 Million CNY | 11.33% |
| 2021 FY | 575.84 Million CNY | 70.72% |
| 2021 Q2 | 156.7 Million CNY | 38.61% |
| 2021 Q1 | 113.05 Million CNY | 0.91% |
| 2021 Q3 | 144.83 Million CNY | -7.57% |
| 2020 FY | 337.3 Million CNY | 17.91% |
| 2020 Q4 | 112.03 Million CNY | 20.46% |
| 2020 Q3 | 93 Million CNY | 11.2% |
| 2020 Q2 | 83.63 Million CNY | 71.95% |
| 2020 Q1 | 48.63 Million CNY | -43.37% |
| 2019 Q3 | 71.73 Million CNY | 0.0% |
| 2019 FY | 286.07 Million CNY | 72.03% |
| 2019 Q4 | 85.88 Million CNY | 19.74% |
| 2018 FY | 166.28 Million CNY | 57.76% |
| 2017 FY | 105.4 Million CNY | 0.0% |